rs2239464

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001110792.2(MECP2):​c.62+14626C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.342 in 110,958 control chromosomes in the GnomAD database, including 5,993 homozygotes. There are 11,427 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.34 ( 5993 hom., 11427 hem., cov: 23)

Consequence

MECP2
NM_001110792.2 intron

Scores

1

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.113
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.756 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MECP2NM_001110792.2 linkuse as main transcriptc.62+14626C>T intron_variant ENST00000453960.7
MECP2NM_004992.4 linkuse as main transcriptc.26+9206C>T intron_variant ENST00000303391.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MECP2ENST00000303391.11 linkuse as main transcriptc.26+9206C>T intron_variant 1 NM_004992.4 P1P51608-1
MECP2ENST00000453960.7 linkuse as main transcriptc.62+14626C>T intron_variant 1 NM_001110792.2 P51608-2

Frequencies

GnomAD3 genomes
AF:
0.342
AC:
37939
AN:
110907
Hom.:
5984
Cov.:
23
AF XY:
0.344
AC XY:
11382
AN XY:
33131
show subpopulations
Gnomad AFR
AF:
0.546
Gnomad AMI
AF:
0.0366
Gnomad AMR
AF:
0.451
Gnomad ASJ
AF:
0.240
Gnomad EAS
AF:
0.780
Gnomad SAS
AF:
0.614
Gnomad FIN
AF:
0.196
Gnomad MID
AF:
0.340
Gnomad NFE
AF:
0.186
Gnomad OTH
AF:
0.369
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.342
AC:
37996
AN:
110958
Hom.:
5993
Cov.:
23
AF XY:
0.344
AC XY:
11427
AN XY:
33192
show subpopulations
Gnomad4 AFR
AF:
0.546
Gnomad4 AMR
AF:
0.452
Gnomad4 ASJ
AF:
0.240
Gnomad4 EAS
AF:
0.780
Gnomad4 SAS
AF:
0.612
Gnomad4 FIN
AF:
0.196
Gnomad4 NFE
AF:
0.186
Gnomad4 OTH
AF:
0.379
Alfa
AF:
0.237
Hom.:
10199
Bravo
AF:
0.374

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.90

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2239464; hg19: chrX-153348431; API